4.6 Letter

Can optimal drug dosing during ECMO improve outcomes?

Journal

INTENSIVE CARE MEDICINE
Volume 39, Issue 12, Pages 2237-2237

Publisher

SPRINGER
DOI: 10.1007/s00134-013-3080-z

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation

Kiran Shekel, Mohd H. Abdul-Aziz, Vesa Cheng, Fay Burrows, Hergen Buscher, Young-Jae Cho, Amanda Corley, Arne Diehl, Eileen Gilder, Stephan M. Jakob, Hyung-Sook Kim, Bianca J. Levkovich, Sung Yoon Lim, Shay McGuinness, Rachael Parke, Vincent Pellegrino, Yok-Ai Que, Claire Reynolds, Sam Rudham, Steven C. Wallis, Susan A. Welch, David Zacharias, John F. Fraser, Jason A. Roberts

Summary: This study aimed to describe the pharmacokinetics of antimicrobials in critically ill patients receiving ECMO and evaluate the effectiveness and safety of current dosing regimens. The study found that there were large variations in antimicrobial concentrations in ECMO patients, leading to poor target attainment rates. Understanding these issues is crucial for the development of appropriate dosing regimens.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

Summary: The clinical risk factors for nephrotoxicity in Staphylococcus aureus bacteraemia are still unclear. In a clinical trial comparing standard therapy to combination therapy, it was found that the combination therapy group had a significantly higher incidence of acute kidney injury.

CLINICAL DRUG INVESTIGATION (2023)

Article Immunology

Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage

Arutha Kulasinghe, Ning Liu, Chin Wee Tan, James Monkman, Jane E. Sinclair, Dharmesh D. Bhuva, David Godbolt, Liuliu Pan, Andy Nam, Habib Sadeghirad, Kei Sato, Gianluigi Li Bassi, Ken O'Byrne, Camila Hartmann, Anna Flavia Ribeiro Dos Santos Miggiolaro, Gustavo Lenci Marques, Lidia Zytynski Moura, Derek Richard, Mark Adams, Lucia de Noronha, Cristina Pellegrino Baena, Jacky Y. Suen, Rakesh Arora, Gabrielle T. Belz, Kirsty R. Short, Melissa J. Davis, Fernando Souza-Fonseca Guimaraes, John F. Fraser

Summary: The study reveals distinct transcriptomic profiles in cardiac tissues of SARS-CoV-2 and pH1N1 influenza infection, with upregulation of genes associated with DNA damage and repair, heat shock, and macrophage infiltration in COVID-19 patients' cardiac tissues. In comparison, pH1N1 infection showed upregulation of interferon and complement pathways. This highlights the need for further understanding of the effects on extra-pulmonary organs, including the cardiovascular system, in COVID-19 patients.

IMMUNOLOGY (2023)

Article Medical Laboratory Technology

Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation

Lucy Sharrock, Melissa J. Ankravs, Adam M. Deane, Thomas Rechnitzer, Steven C. Wallis, Jason A. Roberts, Rinaldo Bellomo

Summary: This study measured the clearance of piperacillin-tazobactam and vancomycin in patients receiving CVVHDF with regional citrate anticoagulation, and found that both drugs have high clearance, providing key information for optimal dosing.

THERAPEUTIC DRUG MONITORING (2023)

Review Virology

Mpox diagnostics: Review of current and emerging technologies

Chuan Kok Lim, Jason Roberts, Michael Moso, Kwee Chin Liew, Mona L. Taouk, Eloise Williams, Thomas Tran, Eike Steinig, Leon Caly, Deborah Ann Williamson

Summary: This review discusses the changes in the epidemiology of monkeypox and the advancements in the understanding of its virology and viral dynamics relevant to diagnostics. It outlines the traditional and emerging laboratory technologies useful for monkeypox virus detection and in guiding elimination strategies. Importantly, the development in MPXV genomics has rapidly advanced our understanding of viral evolution and adaptation in the current outbreak.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Pharmacology & Pharmacy

In silico evaluation of a beta-lactam dosing guideline among adults with serious infections

Paul Williams, Menino Osbert Cotta, Mohd H. H. Abdul-Aziz, Kathryn Wilks, Andras Farkas, Jason A. A. Roberts

Summary: This study aimed to compare the achievement of therapeutic PK-PD exposure targets for beta-lactam antibiotics using product information dosing or guideline-based dosing for serious infections. In silico simulations were performed, and the results showed that guideline-based dosing had significantly higher probability of target attainment at 48 and 96 hours compared to product information dosing. The study also found that eGFR was significantly associated with the %PTA by guideline-based dosing.

PHARMACOTHERAPY (2023)

Article Urology & Nephrology

Serum Creatinine and Tacrolimus Assessment With VAMS Finger-Prick Microsampling: A Diagnostic Test Study

Carla E. Scuderi, Suzanne L. Parker, Margaret Jacks, George T. John, Brett McWhinney, Jacobus Ungerer, Andrew J. Mallett, Helen G. Healy, Jason A. Roberts, Christine E. Staatz

Summary: This study aimed to assess the diagnostic accuracy of using volumetric absorptive microsamplers (VAMS) to measure tacrolimus and creatinine in kidney transplant recipients. The results showed that VAMS can reliably measure tacrolimus and creatinine, providing a less invasive and more frequent sampling method for patients.

KIDNEY MEDICINE (2023)

Article Microbiology

Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients

Pier Giorgio Cojutti, Aaron J. Heffernan, Thomas Tangden, Paola Della Siega, Carlo Tascini, Jason A. Roberts, Federico Pea

Summary: This study aimed to develop a population pharmacokinetic/pharmacodynamic (PK/PD) model of valganciclovir for preemptive therapy of cytomegalovirus (CMV) infection in kidney transplant patients. Ganciclovir concentrations and CMV viral loads were retrospectively obtained from kidney transplant patients. Monte Carlo simulations were conducted to assess the probability of attaining viral load targets, and a PK/PD model was devised.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Engineering, Biomedical

A comprehensive evaluation of hemodynamic energy production and circuit loss using four different ECMO arterial cannulae

Silver Heinsar, Nicole Bartnikowski, Gunter Hartel, Samia M. Farah, E-Peng Seah, Eric Wu, Sebastiano Maria Colombo, Clayton Semenzin, Andrew Haymet, Indrek Ratsep, Jo Pauls, John F. Fraser, Jacky Y. Suen

Summary: This study comprehensively assessed different parameters of pulsatile-flow veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and their contribution to hemodynamic energy production and transfer. The results showed that increasing flow rates and pulsatile amplitudes were associated with higher hemodynamic energy production, while adjusting systole-to-diastole ratio or pulsing frequency had no significant effect. Arterial cannula was found to be the main source of resistance to hemodynamic energy transfer. Increased flow rate and amplitude were the key factors for hemodynamic energy production, while other factors were relevant when combined.

ARTIFICIAL ORGANS (2023)

Article Engineering, Biomedical

Feasibility of pump-controlled retrograde trial off in weaning from veno-arterial ECMO in adults-A single-center case series

Fung Ming Lau, Wai Kit Chan, Yuen Tin Mok, Peter Chi Keung Lai, Sin Kwan Tammy Ma, Chun Wai Ngai, Wai Ching Sin, Wai Ling Phyllis Kwok, Kin Yip Yu, Wai Ming Chan, John F. Fraser, Pauline Yeung Ng

Summary: PCRTO is a weaning technique that involves decremental pump revolutions to achieve retrograde flow, and its application in adults has not been widely reported.

ARTIFICIAL ORGANS (2023)

Review Engineering, Biomedical

Preclinical Studies on Pulsatile Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review

Dhayananth Kanagarajan, Silver Heinsar, Lucia Gandini, Jacky Y. Suen, Van Thanh Dau, Jo Pauls, John F. Fraser

Summary: Refractory cardiogenic shock is currently treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO) without conclusive evidence of improved clinical outcomes. Pulsatile V-A ECMO has been developed as a potential solution to the limitations of continuous-flow devices. A systematic review of preclinical studies on pulsatile V-A ECMO revealed that most studies focused on hemodynamic energy production, while the clinical effects such as heart and brain function, end-organ microcirculation, and inflammation reduction are still inconclusive.

ASAIO JOURNAL (2023)

Article Biochemical Research Methods

Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies

Maria Patricia Hernandez-Mitre, Hayoung Won, Steven C. Wallis, Suzanne L. Parker, Jason A. Roberts

Summary: The aim of this study was to investigate the stability of nafamostat in infusion solutions, during blood sample collection, and in extracted plasma samples in the autosampler. Nafamostat was found to be stable in infusion solutions and in whole blood collected in sodium fluoride/potassium oxalate tubes at 4 degrees C for up to 3 hours before centrifugation. However, nafamostat degraded at a rate of 4.7 +/- 0.7% per hour in extracted plasma samples in the autosampler. In conclusion, viable samples can be obtained using appropriate collection tubes and prompt processing.

BIOANALYSIS (2023)

Review Infectious Diseases

A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations

Eko Setiawan, Menino Osbert Cotta, Jason A. Roberts, Mohd Hafiz Abdul-Aziz

Summary: While inter-ethnic differences in the pharmacokinetic variabilities of antimicrobials have been studied among healthy subjects, further investigation is needed to understand the differences in antimicrobial pharmacokinetics between Asian and non-Asian patients with severe pathologic conditions. A systematic review was conducted to explore the potential variations in antimicrobial pharmacokinetics between Asian and non-Asian populations, with the inclusion of thirty studies on different antimicrobial agents. Inconsistent differences in pharmacokinetic parameters were observed between Asian and non-Asian patients, suggesting that ethnicity may not be a significant predictor in characterizing these differences, and dosing regimens should be adjusted based on demographic or clinical characteristics.

ANTIBIOTICS-BASEL (2023)

Review Infectious Diseases

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity

Amy Legg, Sinead Carmichael, Ming G. Chai, Jason A. Roberts, Menino O. Cotta

Summary: Beta-lactam antibiotics are commonly used in critically ill patients to treat infections, but the optimal exposure targets for these drugs are still debated. Overcoming pharmacokinetic and pharmacodynamic challenges in the intensive care unit is necessary to achieve desired exposures. Therapeutic drug monitoring has shown promise for determining if the desired exposures are reached, but more research is needed to determine its impact on infection-related outcomes. Improving the efficiency of sampling and reporting results in at-risk patients is important for an ideal beta-lactam TDM service.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance

Jason A. Roberts, David P. Nicolau, Ignacio Martin-Loeches, C. Andrew Deryke, Maria C. Losada, Jiejun Du, Munjal Patel, Matthew L. Rizk, Amanda Paschke, Luke F. Chen

Summary: The study aimed to assess the relationship between renal function and the efficacy/safety of imipenem/cilastatin/relebactam for the treatment of HABP/VABP. The results showed that the efficacy of imipenem/cilastatin/relebactam was comparable to piperacillin/tazobactam for participants with various baseline renal functions. However, for participants with normal renal function or CLCR >= 250ml/min, imipenem/cilastatin/relebactam had a higher clinical response rate.

JAC-ANTIMICROBIAL RESISTANCE (2023)

No Data Available